Cargando…

Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer

This cross-sectional study compares the cost and effectiveness of 3 posttreatment strategies for surveillance of human papillomavirus (HPV)–associated oropharyngeal cancer.

Detalles Bibliográficos
Autores principales: Kowalchuk, Roman O., Kamdem Talom, Benjamin C., Van Abel, Kathryn M., Ma, Daniel M., Waddle, Mark R., Routman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790672/
https://www.ncbi.nlm.nih.gov/pubmed/35076706
http://dx.doi.org/10.1001/jamanetworkopen.2021.44783
_version_ 1784640068003037184
author Kowalchuk, Roman O.
Kamdem Talom, Benjamin C.
Van Abel, Kathryn M.
Ma, Daniel M.
Waddle, Mark R.
Routman, David M.
author_facet Kowalchuk, Roman O.
Kamdem Talom, Benjamin C.
Van Abel, Kathryn M.
Ma, Daniel M.
Waddle, Mark R.
Routman, David M.
author_sort Kowalchuk, Roman O.
collection PubMed
description This cross-sectional study compares the cost and effectiveness of 3 posttreatment strategies for surveillance of human papillomavirus (HPV)–associated oropharyngeal cancer.
format Online
Article
Text
id pubmed-8790672
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-87906722022-02-07 Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer Kowalchuk, Roman O. Kamdem Talom, Benjamin C. Van Abel, Kathryn M. Ma, Daniel M. Waddle, Mark R. Routman, David M. JAMA Netw Open Research Letter This cross-sectional study compares the cost and effectiveness of 3 posttreatment strategies for surveillance of human papillomavirus (HPV)–associated oropharyngeal cancer. American Medical Association 2022-01-25 /pmc/articles/PMC8790672/ /pubmed/35076706 http://dx.doi.org/10.1001/jamanetworkopen.2021.44783 Text en Copyright 2022 Kowalchuk RO et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Kowalchuk, Roman O.
Kamdem Talom, Benjamin C.
Van Abel, Kathryn M.
Ma, Daniel M.
Waddle, Mark R.
Routman, David M.
Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
title Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
title_full Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
title_fullStr Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
title_full_unstemmed Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
title_short Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
title_sort estimated cost of circulating tumor dna for posttreatment surveillance of human papillomavirus–associated oropharyngeal cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790672/
https://www.ncbi.nlm.nih.gov/pubmed/35076706
http://dx.doi.org/10.1001/jamanetworkopen.2021.44783
work_keys_str_mv AT kowalchukromano estimatedcostofcirculatingtumordnaforposttreatmentsurveillanceofhumanpapillomavirusassociatedoropharyngealcancer
AT kamdemtalombenjaminc estimatedcostofcirculatingtumordnaforposttreatmentsurveillanceofhumanpapillomavirusassociatedoropharyngealcancer
AT vanabelkathrynm estimatedcostofcirculatingtumordnaforposttreatmentsurveillanceofhumanpapillomavirusassociatedoropharyngealcancer
AT madanielm estimatedcostofcirculatingtumordnaforposttreatmentsurveillanceofhumanpapillomavirusassociatedoropharyngealcancer
AT waddlemarkr estimatedcostofcirculatingtumordnaforposttreatmentsurveillanceofhumanpapillomavirusassociatedoropharyngealcancer
AT routmandavidm estimatedcostofcirculatingtumordnaforposttreatmentsurveillanceofhumanpapillomavirusassociatedoropharyngealcancer